Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Angelidakis, G."'
Autor:
Angelidakis G; Departments of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Chemaly RF; Departments of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Sahasrabhojane PV; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Platform for Innovative Microbiome and Translational Research, The University of Texas MD Anderson Cancer, Houston, TX 77030, USA ., Morado-Aramburo O; Departments of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Jiang Y; Departments of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Bhatti MM; Department of Clinical Microbiology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Shpall E; Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Hosing C; Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Jain P; Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Mahadeo KM; Department of Pediatrics, Division of Pediatric Transplant and Cellular Therapy, Duke University School of Medicine, Durham, NC 27705, USA., Khawaja F; Departments of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Elhajj P; Departments of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wargo JA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Platform for Innovative Microbiome and Translational Research, The University of Texas MD Anderson Cancer, Houston, TX 77030, USA .; Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Jenq RR; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Platform for Innovative Microbiome and Translational Research, The University of Texas MD Anderson Cancer, Houston, TX 77030, USA ., Ajami NJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Platform for Innovative Microbiome and Translational Research, The University of Texas MD Anderson Cancer, Houston, TX 77030, USA ., Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ariza-Heredia EJ; Departments of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Publikováno v:
Vaccines [Vaccines (Basel)] 2024 Sep 19; Vol. 12 (9). Date of Electronic Publication: 2024 Sep 19.
Autor:
El Haddad L; Department of Medicine, University of Florida, 2033 Mowry Rd, Gainesville, FL 32610, USA., Angelidakis G; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhai Y; Department of Animal Sciences, University of Florida, Gainesville, FL 32610, USA.; Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA., Yaghi L; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Arias CA; Division of Infectious Diseases, Houston Methodist Hospital, Houston, TX 77030, USA.; Center for Infectious Diseases, Houston Methodist Research Institute, Houston, TX 77030, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA., Shelburne SA; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Jeong KC; Department of Animal Sciences, University of Florida, Gainesville, FL 32610, USA.; Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA., Chemaly RF; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Publikováno v:
Microorganisms [Microorganisms] 2024 Aug 14; Vol. 12 (8). Date of Electronic Publication: 2024 Aug 14.
Autor:
Khawaja F; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ahmed S; Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Division of Cancer Medicine, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Iyer SP; Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sassine J; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Infectious Diseases Section, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA., Handley G; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Division of Infectious Disease and International Medicine, Department of Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA., Prakash R; Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., VanWierren T; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jackson J; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zubovskaia A; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ramdial J; Division of Cancer Medicine, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rondon G; Division of Cancer Medicine, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel KK; Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Spallone A; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ariza-Heredia EJ; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Mulanovich V; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Angelidakis G; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jiang Y; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chemaly RF; Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2024 Jul 18; Vol. 11 (8), pp. ofae422. Date of Electronic Publication: 2024 Jul 18 (Print Publication: 2024).
Publikováno v:
Journal of Hepatocellular Carcinoma, Vol Volume 5, Pp 81-86 (2018)
Dima Dandachi,1,2 Manal Hassan,3 Ahmed Kaseb,4 Georgios Angelidakis,2 Harrys A Torres2,4 1Department of Infectious Diseases, Baylor College of Medicine, Houston, TX, USA; 2Department of Infectious Diseases, Infection Control and Employee Health, The
Externí odkaz:
https://doaj.org/article/e9162b55f0bc4e1e8286737e69a98c32
Autor:
Torres HA; 1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX.; 2Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX., Mustafayev K; 1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX., Juneau RP; 3Information Services-Liaison Program, Epic Boost, Epic, Verona, WI., Hwang JP; 4Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Wang LS; 2Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX., Angelidakis G; 1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX., Hawk E; 5Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX., Granwehr BP; 1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX., Yepez Guevara E; 1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX., Ying AK; 6Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 May 10; Vol. 22 (2 D). Date of Electronic Publication: 2024 May 10.
Autor:
Khawaja F; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Angelidakis G; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Feldman A; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ravi V; Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Woodman E; Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bhatti M; Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ariza-Heredia E; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Elhajj P; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Spallone A; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jiang Y; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chemaly RF; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2023 Dec; Vol. 12 (24), pp. 22006-22022. Date of Electronic Publication: 2023 Dec 08.
Autor:
Yibirin M; Departments of Infectious Diseases, Infection Control and Employee Health., Hosry J; Departments of Infectious Diseases, Infection Control and Employee Health., Yepez Guevara E; Departments of Infectious Diseases, Infection Control and Employee Health., Granwehr BP; Departments of Infectious Diseases, Infection Control and Employee Health., Jiang Y; Departments of Infectious Diseases, Infection Control and Employee Health., Mustafayev K; Departments of Infectious Diseases, Infection Control and Employee Health., Angelidakis G; Departments of Infectious Diseases, Infection Control and Employee Health., Torres HA; Departments of Infectious Diseases, Infection Control and Employee Health.; Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
European journal of gastroenterology & hepatology [Eur J Gastroenterol Hepatol] 2022 Oct 01; Vol. 34 (10), pp. 1098-1101. Date of Electronic Publication: 2022 Aug 24.
Autor:
Hosry J; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Miranda RN; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Samaniego F; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Angelidakis G; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Torres HA; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Hematological oncology [Hematol Oncol] 2020 Aug; Vol. 38 (3), pp. 301-308. Date of Electronic Publication: 2020 Apr 01.
Autor:
Torres HA; Department of Infectious Diseases, Infection Control and Employee Health, the University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Gastroenterology, Hepatology and Nutrition, the University of Texas MD Anderson Cancer Center, Houston, TX., Angelidakis G; Department of Infectious Diseases, Infection Control and Employee Health, the University of Texas MD Anderson Cancer Center, Houston, TX., Jiang Y; Department of Infectious Diseases, Infection Control and Employee Health, the University of Texas MD Anderson Cancer Center, Houston, TX., Economides M; Department of Infectious Diseases, Infection Control and Employee Health, the University of Texas MD Anderson Cancer Center, Houston, TX., Mustafayev K; Department of Infectious Diseases, Infection Control and Employee Health, the University of Texas MD Anderson Cancer Center, Houston, TX., Yibirin M; Department of Infectious Diseases, Infection Control and Employee Health, the University of Texas MD Anderson Cancer Center, Houston, TX., Orlowski R; Department of Lymphoma/Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX., Champlin R; Department of Stem Cell Transplantation, the University of Texas MD Anderson Cancer Center, Houston, TX., Verstovsek S; Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX., Raad I; Department of Infectious Diseases, Infection Control and Employee Health, the University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Medicine [Medicine (Baltimore)] 2022 Sep 16; Vol. 101 (37), pp. e30608.
Autor:
El Haddad L; Department of Medicine, University of Florida, Gainesville, FL 32611, USA., Angelidakis G; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Clark JR; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Mendoza JF; Department of Medicine, University of Florida, Gainesville, FL 32611, USA., Terwilliger AL; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Chaftari CP; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Duna M; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Yusuf ST; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Harb CP; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Stibich M; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Xenex Disinfection Services, San Antonio, TX 78216, USA., Maresso A; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Chemaly RF; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2022 Jul 30; Vol. 14 (8). Date of Electronic Publication: 2022 Jul 30.